A population‐based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2018.09.018
Abstract: Background: Differences in relative survival (RS) of melanoma between histologic subtypes were discussed to be mainly caused by tumor thickness. Objective: To investigate RS of melanoma, stratified by tumor thickness for each histologic subtype, and… read more here.
Keywords: melanoma; tumor thickness; histologic subtype;
Melanoma pathology reporting and staging
Sign Up to like & getrecommendations! Published in 2019 at "Modern Pathology"
DOI: 10.1038/s41379-019-0402-x
Abstract: The pathological diagnosis of melanoma can be challenging. The provision of an appropriate biopsy and pertinent history can assist in establishing an accurate diagnosis and reliable estimate of prognosis. In their reports, pathologists should document… read more here.
Keywords: melanoma; melanoma pathology; prognostic parameters; pathology ... See more keywords
Computer-aided clinical image analysis for non-invasive assessment of tumor thickness in cutaneous melanoma
Sign Up to like & getrecommendations! Published in 2021 at "BMC Research Notes"
DOI: 10.1186/s13104-021-05650-4
Abstract: Objective Computerized clinical image analysis is shown to improve diagnostic accuracy for cutaneous melanoma but its effectiveness in preoperative assessment of melanoma thickness has not been studied. The aim of this study, is to explore… read more here.
Keywords: melanoma; color; cutaneous melanoma; tumor thickness ... See more keywords
Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14184410
Abstract: Simple Summary Unlike the neutrophil/lymphocyte ratio (NLR), more complex complete blood count (CBC)-based systemic immune-inflammation cancer biomarkers have recently been proposed, such as the pan-immune-inflammation value (PIV). We aimed to assess both NLR and PIV… read more here.
Keywords: age tumor; stage iii; tumor thickness; immune inflammation ... See more keywords